In the past week, BEAT stock has gone down by -2.25%, with a monthly gain of 5.24% and a quarterly surge of 29.85%. The volatility ratio for the week is 8.82%, and the volatility levels for the last 30 days are 10.33% for HeartBeam Inc The simple moving average for the past 20 days is -5.76% for BEAT’s stock, with a 32.62% simple moving average for the past 200 days.
Is It Worth Investing in HeartBeam Inc (NASDAQ: BEAT) Right Now?
BEAT has 36-month beta value of -0.94. Analysts have mixed views on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 1 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for BEAT is 19.23M, and currently, short sellers hold a 1.78% ratio of that float. The average trading volume of BEAT on August 01, 2024 was 118.73K shares.
BEAT) stock’s latest price update
The stock of HeartBeam Inc (NASDAQ: BEAT) has increased by 10.13 when compared to last closing price of 2.37.Despite this, the company has seen a loss of -2.25% in its stock price over the last five trading days. businesswire.com reported 2024-06-25 that SALT LAKE CITY–(BUSINESS WIRE)–Epitel, a leader in AI technologies for patient-focused brain health solutions, announced today the addition of wearables industry pioneer Ken Nelson to its Board of Directors. With his extensive experience in digital health, medical devices, and remote patient monitoring, Nelson will play a crucial role in guiding Epitel’s growth as the company continues to transform the landscape of brain monitoring through AI/ML and its wearable EEG technology. Ken Nelson bri.
BEAT Trading at 0.22% from the 50-Day Moving Average
After a stumble in the market that brought BEAT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -22.99% of loss for the given period.
Volatility was left at 10.33%, however, over the last 30 days, the volatility rate increased by 8.82%, as shares sank -11.53% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +26.09% upper at present.
During the last 5 trading sessions, BEAT fell by -2.25%, which changed the moving average for the period of 200-days by +62.11% in comparison to the 20-day moving average, which settled at $2.75. In addition, HeartBeam Inc saw 11.06% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at BEAT starting from de Urioste George, who sale 5,500 shares at the price of $2.06 back on Sep 29 ’23. After this action, de Urioste George now owns 36,129 shares of HeartBeam Inc, valued at $11,330 using the latest closing price.
de Urioste George, the Director of HeartBeam Inc, sale 8,000 shares at $2.04 during a trade that took place back on Sep 28 ’23, which means that de Urioste George is holding 41,629 shares at $16,320 based on the most recent closing price.
Stock Fundamentals for BEAT
The total capital return value is set at -1.27. Equity return is now at value -258.74, with -200.17 for asset returns.
Currently, EBITDA for the company is -15.31 million with net debt to EBITDA at 0.79. The liquidity ratio also appears to be rather interesting for investors as it stands at 12.07.
Conclusion
To put it simply, HeartBeam Inc (BEAT) has had a mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
